# Efficacy of Low-dose Venetoclax With Itraconazole + TACL for R/R ALL Patients

> **NCT07039877** · PHASE2 · RECRUITING · sponsor: **Hospital Universitario Dr. Jose E. Gonzalez** · enrollment: 12 (estimated)

## Conditions studied

- Acute Lymphobkastic Leukemia
- Acute Lymphoblastic Leukaemia Recurrent
- Philadelphia Chromosome Negative ALL

## Interventions

- **DRUG:** Venetoclax low dose with itraconazole

## Key facts

- **NCT ID:** NCT07039877
- **Lead sponsor:** Hospital Universitario Dr. Jose E. Gonzalez
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-02
- **Primary completion:** 2026-02-28
- **Final completion:** 2026-04-30
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2025-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07039877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07039877, "Efficacy of Low-dose Venetoclax With Itraconazole + TACL for R/R ALL Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07039877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*